RESEARCH TRIANGLE PARK – Novartis AG shares closed up 76 cents to $91.60 on Thursday on news of a lawsuit settlement.
The pharmaceutical company is reportedly paying $245 million to settle an antitrust case over a hypertension drug.
Reuters has full details on the settlement: https://www.pharmalive.com/novartis-to-pay-245m-to-end-antitrust-cases-over-exforge-drug-generics/
